VIRMA and chronic myelogenous leukemia, BCR-ABL1 positive: Notably, KIAA1429 regulated the total level of RNA m6A modification in the CML cells and promoted the malignant biological behaviors of CML cells, including proliferation, migration, and imatinib resistance.